COMP <GO>
ENSG vs UHS // ALTMAN Z-SCORE & DEBT/EQUITY
The Ensign Group Inc. (NASDAQ) VS. Universal Health Services Inc. (NYSE) • 15-METRIC TALLY: ENSG 5
— UHS 8
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: ENSG
LAST: $179.06 (-1.35%) • MKT CAP: $10.59B
balance-sheet
3.73
LAST: $180.65 (+2.61%) • MKT CAP: $10.38B
balance-sheet
3.11
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ENSG VS. UHS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ENSG | UHS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.00% | 14.10% | +3.90 | ENSG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 5.0x | +12.00 | UHS | /valuation <GO> |
| Free Cash Flow Yield | 3.11% | 8.16% | -5.05 | UHS | /fcf-yield <GO> |
| Operating Margin | 8.50% | 11.50% | -3.00 | UHS | /operating-margins <GO> |
| Net Profit Margin | 6.80% | 8.60% | -1.80 | UHS | /net-margins <GO> |
| Revenue Growth (YoY) | 18.80% | 9.70% | +9.10 | ENSG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.13% | 0.49% | -0.36 | UHS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 3.73 | 3.11 | +0.62 | ENSG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | UHS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.1 | 45.7 | +8.40 | ENSG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 1.04 | -0.15 | UHS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.5x | 6.5x | +20.00 | UHS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.59B | $10.38B | $214.2M | ENSG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ENSG REV | UHS REV | ENSG GROSS % | UHS GROSS % | ENSG FCF | UHS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.03B | $17.36B | 20.1% | — | $337.8M | $849.2M |
| FY 2024 | $4.24B | $15.83B | 20.3% | — | $156.5M | $1.12B |
| FY 2023 | $3.71B | $14.28B | — | — | $209.8M | $625.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ENSG // BETA 0.89
UHS // BETA 1.04